Pfizer Inc. PFE, -0.31% and BioNTech SE BNTX, + 2.80% He said Monday night that they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, which involves 30,000 people worldwide. The start of the trial “is a great step forward in our progress towards the provision …
Read More »Pfizer, BioNTech Stocks Increase After COVID-19 Vaccine Candidates Earn Fast Track Designation
Shares of Pfizer Inc. PFE, + 1.10% gathered 2.3% and BioNTech SE BNTX, + 7.24% On Monday, it rose 5.3% in premarket trading, after companies said two of their vaccine candidates to protect themselves against the virus that causes COVID-19 received the Fast Track designation status from the Administration. Food …
Read More »